| RGSVX | VCRAX | RGSVX / VCRAX | |
| Total Expense Ratio | 0.86 | 1.24 | 69% |
| Annual Report Gross Expense Ratio | 1.06 | 1.24 | 85% |
| Fund Existence | 10 years | 13 years | - |
| Gain YTD | 11.163 | 8.399 | 133% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000000 | 15000 | 6,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 172M | 1.71B | 10% |
| Annual Yield % from dividends | 3.23 | 1.39 | 233% |
| Returns for 1 year | 16.50 | 9.79 | 169% |
| Returns for 3 years | 54.98 | 44.43 | 124% |
| Returns for 5 years | 43.81 | 32.23 | 136% |
| Returns for 10 years | 114.55 | 64.05 | 179% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FISGX | 44.85 | 0.39 | +0.88% |
| Nuveen Small/Mid Cap Growth Opp I | |||
| PHSZX | 53.79 | 0.40 | +0.75% |
| PGIM Jennison Health Sciences Z | |||
| XLSR | 66.05 | 0.27 | +0.42% |
| State Street® US Sector Rotation ETF | |||
| ACCLX | 16.74 | 0.07 | +0.42% |
| American Century Mid Cap Value C | |||
| VVSGX | 20.42 | N/A | N/A |
| VALIC Company I Small Cap Growth | |||